| Inlyta1 mg film-coated tablets EU/1/12/777/001-003 |
Axitinib |
Pfizer Europe MA EEIG |
— |
| Levetiracetam Hospira 100 mg/ml concentrate for solution for infusion EU/1/13/889/001-002 |
Levetiracetam |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/001 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/002-004 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/005-007 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/008-010 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/011-013 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Litfulo 50 mg hard capsules EU/1/23/1755/001-003 |
Ritlecitinib |
Pfizer Europe MA EEIG |
— |
| Lorviqua 100 mg film-coated tablet EU/1/19/1355/002 |
LORLATINIB |
Pfizer Europe MA EEIG |
— |
| Lorviqua 25 mg film-coated tablets EU/1/19/1355/001 |
LORLATINIB |
Pfizer Europe MA EEIG |
— |
| MYLOTARG 5 mg powder for concentrate for solution for infusion EU/1/18/1277/001 |
Gemtuzumab ozogamicin |
Pfizer Europe MA EEIG |
— |
| NGENLA 24 mg/ 1.2 ml Solution for injection EU/1/21/1617/001 |
Somatrogon |
Pfizer Europe MA EEIG |
— |
| NGENLA 60 mg/ 1.2 ml Solution for injection EU/1/21/1617/002 |
Somatrogon |
Pfizer Europe MA EEIG |
— |
| Nimenrix powder and solvent for solution for injection in pre-filled syringe EU/1/12/767/001-007 |
N.meningitidis serogroup a polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup c polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup w polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup y polysaccharide conjugated to tetanus toxoid |
Pfizer Europe MA EEIG |
— |
| Nivestim 12 MU/0.2 ml solution for injection/infusion EU/1/10/631/001-3 |
Filgrastim |
Pfizer Europe MA EEIG |
— |
| Nivestim 30 MU/0.2 ml solution for injection/infusion EU/1/10/631/004-6 |
Filgrastim |
Pfizer Europe MA EEIG |
— |
| Nivestim 48 MU/0.2 ml solution for injection/infusion EU/1/10/631/007-9 |
Filgrastim |
Pfizer Europe MA EEIG |
— |
| Nyvepria 6 mg solution for injection EU/1/20/1486/001 |
Pegfilgrastim |
Pfizer Europe MA EEIG |
— |
| Oxbryta EU/1/21/1622/001 |
Voxelotor |
Pfizer Europe MA EEIG |
— |
| Paxlovid 150 mg + 100 mg Film-coated tablet EU/1/22/1625/001 |
PF-07321332 |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion EU/1/15/1057/003 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion EU/1/17/1183/003 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion EU/1/15/1057/001 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion EU/1/17/1183/001 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 25 mg/ml concentrate for solution for infusion EU/1/15/1057/004-006 |
Pemetrexed Disodium Hemipentahydrate, Pemetrexed |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion EU/1/15/1057/002 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion EU/1/17/1183/002 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Prevenar 13 suspension for injection pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) EU/1/09/590/1-6 |
Polysaccharide serotype 14, Polysaccharide serotype 23f, Polysaccharide serotype 19f, Polysaccharide serotype 9v, Polysaccharide serotype 3 |
Pfizer Europe MA EEIG |
— |
| Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) EU/1/21/1612/001-006 |
Pneumococcal polysaccharide serotype 1, Pneumococcal Polysaccharide Serotype 3, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal Polysaccharide Serotype 6A |
Pfizer Europe MA EEIG |
— |
| Rapamune EU/1/01/171/14 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 0.5 mg Coated tablet EU/1/01/171/013-014 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/007 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/008 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg/ml Oral solution EU/1/01/171/001 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 2 mg Coated tablet EU/1/01/171/009-010 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 1000 IU powder and solvent for solution for injection EU/1/99/103/003 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 1000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/007 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection EU/1/99/103/004 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/008 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 250 IU powder and solvent for solution for injection EU/1/99/103/001 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/005 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection EU/1/99/103/002 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/006 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| Retacrit EU/1/07/431/17-19 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit EU/1/07/431/7-16 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit 1000 IU/0.3 ml Solution for injection EU/1/07/431/1-6 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Ruxience 100 mg concentrate for solution for infusion EU/1/20/1431/001 |
Rituximab |
Pfizer Europe MA EEIG |
— |
| Ruxience 500 mg concentrate for solution for infusion EU/1/20/1431/002 |
Rituximab |
Pfizer Europe MA EEIG |
— |
| Somavert EU/1/02/240/1-3 |
Pegvisomant |
Pfizer Europe MA EEIG |
— |
| Somavert 25 mg powder and solvent for solution for injection EU/1/02/240/009-010 |
Pegvisomant |
Pfizer Europe MA EEIG |
— |